iRhythm Technologies, Inc.

SCM employs fundamental, bottom-up, and company-focused research in their investment process. They maintain a single growth-oriented philosophy that is applied across all strategies. The Select Growth strategy provides clients with exposure to their growth opportunities through a concentrated portfolio of primarily large- and mid-capitalization growth businesses. Portfolio companies are primarily domiciled in the US but also include the equity securities of issuers in other developed and emerging markets. The firm's Global Growth strategy is a concentrated portfolio that typically includes issuers that are domiciled in both developed and emerging markets. Their Global Leaders strategy is almost the same with the Global Growth strategy. Sands' Emerging Markets Growth strategy is a concentrated portfolio that typically includes issuers that are domiciled in or have significant exposure to emerging and frontier markets. The firm's Technology Innovators strategy is a concentrated portfolio of growth businesses which may be publicly or privately held, with a particular emphasis placed on companies classified in the technology sector, typically including issuers. Sands' Focus strategy is a concentrated portfolio of primarily large-capitalization growth businesses that typically includes issuers. Portfolio companies are selected from Sands' other equity strategies.

BCM provides investment services to clients on an individual basis, taking into consideration each client's investment objectives, goals, circumstances, and investment needs. When selecting securities and determining the total amount to be purchased or sold, the firm observes the investment policies, limitations and restrictions of the client accounts for which it advises. Their primary approach in evaluating securities is fundamental analysis. The investment strategy employed by BCM generally involves establishing long-term positions. The principal drivers for their sell discipline are: (1) when the fundamentals that spurred the original investment change adversely; (2) the security becomes overvalued, or; (3) it is determined that the security has been an investment mistake. Short sales, margin transactions and options (in all forms) are not utilized.

WBIM is an active investment manager that utilizes a variety of methods and strategies to make investment decisions and recommendations. The firm employs both fundamental and technical research methods when evaluating investment opportunities. They offer a broad range of equity, fixed income, multi-asset, multi-currency, and systematic investment styles to clients.

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Synergy Life Science Partners focuses on investments in private, US early-stage medical device companies and emerging companies combine medical devices with therapeutic payloads such as drugs or biologics. The firm focuses on early-stage companies operating in large therapeutic areas including: cardiovascular, orthopedics/spine, ophthalmology, obesity/diabetes, oncology, gastro-intestinal disease, central and peripheral nervous system, aesthetics, genito-urinary and respiratory disease. They look for companies with productive, domain-experienced management teams and big ideas that are backed with focused, capital efficient, clinically-driven development plans and sound business models. Synergy Life Science Partners also looks for companies with unchallenged intellectual property that can maximize the platform's potential. Companies must have predictable and capital efficient regulatory and clinical paths and clear paths to procure adequate reimbursement. The firm invests in early-stage companies that are raising their first or second round of venture financing, that have met proof-of-concept. Synergy invests a portion of their funds in opportunities originated through Synecor, a medical incubator founded in 2000 by Richard Stack and Bill Starling.

California HealthCare Foundation invests in companies located in US. The firm targets companies operating in the fields of health care services and information technology services. They provides financing for debt and buyout transactions.